世界の抗核抗体(ANA)検査市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Anti-nuclear Antibody (ANA) Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:102
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、抗核抗体(ANA)検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗核抗体(ANA)検査の種類別市場規模(間接蛍光抗体法、酵素免疫測定法(ELISA)、その他)、用途別市場規模(病院、クリニック、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Abcam、Antibodies、Bio-Rad Laboratories、Alere、Erba Diagnostics、MBL International、Merck、Indur Services、Trinity Biotech、Thermo Fisher Scientific、Zeus Scientific
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:間接蛍光抗体法、酵素免疫測定法(ELISA)、その他
・用途別分析2016年-2026年:病院、クリニック、その他
・抗核抗体(ANA)検査の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・抗核抗体(ANA)検査のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・抗核抗体(ANA)検査のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・抗核抗体(ANA)検査の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・抗核抗体(ANA)検査の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Anti-nuclear Antibody (ANA) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Anti-nuclear Antibody (ANA) Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Anti-nuclear Antibody (ANA) Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Anti-nuclear Antibody (ANA) Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Indirect Immunofluorescence
Enzyme-linked Immunosorbent Assay (ELISA)
Other

Market segment by Application, can be divided into
Hospital
Clinic
Other

Market segment by players, this report covers
Abcam
Antibodies
Bio-Rad Laboratories
Alere
Erba Diagnostics
MBL International
Merck
Indur Services
Trinity Biotech
Thermo Fisher Scientific
Zeus Scientific

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Anti-nuclear Antibody (ANA) Testing
1.2 Classification of Anti-nuclear Antibody (ANA) Testing by Type
1.2.1 Overview: Global Anti-nuclear Antibody (ANA) Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type in 2020
1.2.3 Indirect Immunofluorescence
1.2.4 Enzyme-linked Immunosorbent Assay (ELISA)
1.2.5 Other
1.3 Global Anti-nuclear Antibody (ANA) Testing Market by Application
1.3.1 Overview: Global Anti-nuclear Antibody (ANA) Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Anti-nuclear Antibody (ANA) Testing Market Size & Forecast
1.5 Global Anti-nuclear Antibody (ANA) Testing Market Size and Forecast by Region
1.5.1 Global Anti-nuclear Antibody (ANA) Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Anti-nuclear Antibody (ANA) Testing Market Size by Region, (2016-2021)
1.5.3 North America Anti-nuclear Antibody (ANA) Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Anti-nuclear Antibody (ANA) Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size and Prospect (2016-2026)
1.5.6 South America Anti-nuclear Antibody (ANA) Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Anti-nuclear Antibody (ANA) Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-nuclear Antibody (ANA) Testing Market Drivers
1.6.2 Anti-nuclear Antibody (ANA) Testing Market Restraints
1.6.3 Anti-nuclear Antibody (ANA) Testing Trends Analysis
2 Company Profiles
2.1 Abcam
2.1.1 Abcam Details
2.1.2 Abcam Major Business
2.1.3 Abcam Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.1.4 Abcam Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abcam Recent Developments and Future Plans
2.2 Antibodies
2.2.1 Antibodies Details
2.2.2 Antibodies Major Business
2.2.3 Antibodies Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.2.4 Antibodies Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Antibodies Recent Developments and Future Plans
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business
2.3.3 Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.3.4 Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.4 Alere
2.4.1 Alere Details
2.4.2 Alere Major Business
2.4.3 Alere Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.4.4 Alere Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Alere Recent Developments and Future Plans
2.5 Erba Diagnostics
2.5.1 Erba Diagnostics Details
2.5.2 Erba Diagnostics Major Business
2.5.3 Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.5.4 Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Erba Diagnostics Recent Developments and Future Plans
2.6 MBL International
2.6.1 MBL International Details
2.6.2 MBL International Major Business
2.6.3 MBL International Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.6.4 MBL International Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 MBL International Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.7.4 Merck Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Merck Recent Developments and Future Plans
2.8 Indur Services
2.8.1 Indur Services Details
2.8.2 Indur Services Major Business
2.8.3 Indur Services Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.8.4 Indur Services Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Indur Services Recent Developments and Future Plans
2.9 Trinity Biotech
2.9.1 Trinity Biotech Details
2.9.2 Trinity Biotech Major Business
2.9.3 Trinity Biotech Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.9.4 Trinity Biotech Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Trinity Biotech Recent Developments and Future Plans
2.10 Thermo Fisher Scientific
2.10.1 Thermo Fisher Scientific Details
2.10.2 Thermo Fisher Scientific Major Business
2.10.3 Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.10.4 Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.11 Zeus Scientific
2.11.1 Zeus Scientific Details
2.11.2 Zeus Scientific Major Business
2.11.3 Zeus Scientific Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.11.4 Zeus Scientific Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Zeus Scientific Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Anti-nuclear Antibody (ANA) Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Anti-nuclear Antibody (ANA) Testing Players Market Share
3.2.2 Top 10 Anti-nuclear Antibody (ANA) Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Anti-nuclear Antibody (ANA) Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Anti-nuclear Antibody (ANA) Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Anti-nuclear Antibody (ANA) Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Application (2016-2021)
5.2 Anti-nuclear Antibody (ANA) Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2026)
6.2 North America Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2026)
6.3 North America Anti-nuclear Antibody (ANA) Testing Market Size by Country
6.3.1 North America Anti-nuclear Antibody (ANA) Testing Revenue by Country (2016-2026)
6.3.2 United States Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2026)
7.2 Europe Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2026)
7.3 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country
7.3.1 Europe Anti-nuclear Antibody (ANA) Testing Revenue by Country (2016-2026)
7.3.2 Germany Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
7.3.3 France Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region
8.3.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue by Region (2016-2026)
8.3.2 China Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
8.3.5 India Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2026)
9.2 South America Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2026)
9.3 South America Anti-nuclear Antibody (ANA) Testing Market Size by Country
9.3.1 South America Anti-nuclear Antibody (ANA) Testing Revenue by Country (2016-2026)
9.3.2 Brazil Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country
10.3.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Revenue by Country (2016-2026)
10.3.2 Turkey Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

...

【掲載企業】

Abcam、Antibodies、Bio-Rad Laboratories、Alere、Erba Diagnostics、MBL International、Merck、Indur Services、Trinity Biotech、Thermo Fisher Scientific、Zeus Scientific

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の抗核抗体(ANA)検査市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Anti-nuclear Antibody (ANA) Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。